Dai ichi Life Insurance Company Ltd Lowers Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Dai ichi Life Insurance Company Ltd lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 18.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,986 shares of the medical equipment provider's stock after selling 3,725 shares during the quarter. Dai ichi Life Insurance Company Ltd's holdings in Intuitive Surgical were worth $8,345,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Mirador Capital Partners LP raised its holdings in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock valued at $1,732,000 after acquiring an additional 50 shares during the period. Consolidated Planning Corp raised its holdings in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock valued at $3,979,000 after acquiring an additional 1,198 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider's stock valued at $39,622,000 after acquiring an additional 76,649 shares during the period. Swiss National Bank raised its holdings in Intuitive Surgical by 0.3% during the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider's stock valued at $517,209,000 after acquiring an additional 3,400 shares during the period. Finally, ABLE Financial Group LLC bought a new stake in Intuitive Surgical during the 3rd quarter valued at $604,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $4.70 during mid-day trading on Tuesday, hitting $541.25. The company's stock had a trading volume of 623,936 shares, compared to its average volume of 1,455,160. The stock has a market cap of $192.78 billion, a price-to-earnings ratio of 86.85, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. The business has a 50 day moving average price of $505.63 and a 200-day moving average price of $465.19. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have issued reports on ISRG. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an "overweight" rating in a report on Friday, October 18th. Redburn Atlantic upgraded shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and boosted their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Piper Sandler restated an "overweight" rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Robert W. Baird boosted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $526.06.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,655,048.26. This represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,539 shares of company stock valued at $26,112,364 over the last three months. Insiders own 0.80% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.